News
-
December 17, 2018
Precision Medicine Group Acquires Stern Investor Relations, Inc.
Learn more -
November 14, 2018
Circulating Tumor Cells Detected from Angiosarcoma Cancer Patients with use of ApoStream® Technology...
DISCOVER MORE -
October 16, 2018
Precision for Medicine Acquires Liquid Biopsy and Tissue Profiling Pioneer ApoCell
GET THE STORY
Recent advancements have catapulted the healthcare industry into an unprecedented time of change and development. To keep pace, pharmaceutical and life sciences companies need insight infused with foresight.
Precision Medicine Group can help with support through every stage of product research, development and commercialization.
We are a symbiotic team of established experts, gathered specifically to surmount challenges facing the advancement of precision medicine. A cohesive force combining decades of experience, we partner with our clients from molecule to medicine cabinet, helping develop products that are as successful in the market as they are in vivo –
impacting the lives of people everywhere with important breakthroughs and life-improving advances.